SCIPI Implementation and Evaluation: A Multi-site Proof-of-Concept Pilot Trial
Part of paid clinical trials in San Antonio, Texas.
- Sponsor
- The University of Texas Health Science Center at San Antonio
- Study ID
- NCT07280897
- Status
- Not Yet Recruiting
Notify me when recruiting opens
Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.
Add your contact details and location so we can keep your interest tied to this study.
Conditions
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- SCIPI — BEHAVIORALSCIPI (Support, Communication, and Information Program for Prostate Cancer - Interactive) is a web-based supportive care program delivered through the Epic MyChart system. The program provides tailored educational materials, skills training, and interactive tools to support informed treatment decision-making for patients with localized prostate cancer.
Study Details
This study will test a web-based supportive care program called the Support, Communication, and Information Program for Prostate Cancer - Interactive (SCIPI). SCIPI provides men with localized prostate cancer and their families with easy-to-understand information, tools to prepare for discussions with their doctors, and opportunities for social support. The purpose of this pilot study is to determine whether it is feasible to integrate SCIPI in prostate cancer clinical care via the electronic medical record and whether SCIPI may improve patients' confidence in making treatment decisions and their overall quality of life compared with usual care. The study will include patients who are newly diagnosed with prostate cancer. Participants will be randomly assigned to use SCIPI or to receive usual care, and information will be collected over time about their experiences, decision-making, and quality of life.
Key Dates
- Start date
- Oct 1, 2026
- Status verified
- Dec 2025
- Primary completion
- Sep 29, 2029
- Completion
- Sep 29, 2029
Study Design
- Enrollment
- 200 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- SUPPORTIVE_CARE
Arms
- Experimental: SCIPIParticipants will receive SCIPI, a web-based supportive care program delivered through the Epic MyChart system, in addition to usual care.
- No Intervention: Usual CareParticipants will receive usual care provided at their study site.
Primary Outcome Measure
Satisfaction with Decision (SWD) [ Time Frame: 3-month follow-up (T2) and 6-month follow-up (T3) ]
Central Contacts
- Lixin Song, PhD210-450-8561
- Cheongin Im, PhD210-567-5102
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| The University of Texas Health Science Center at San Antonio School of Nursing | San Antonio | Texas | 78229 |
Find similar trials in San Antonio, TX
Related Studies
- Adjuvant Curcumin to Assess Recurrence Free Survival in Patients Who Have Had a Radical ProstatectomyPHASE3 · Recruiting · yair lotan · Dallas, Texas
- A Study for Subjects With Prostate Cancer Who Previously Participated in an Enzalutamide Clinical StudyPHASE2 · Recruiting · Astellas Pharma Global Development, Inc. · Anchorage, Alaska
- International Registry for Men With Advanced Prostate Cancer (IRONMAN)Recruiting · Prostate Cancer Clinical Trials Consortium · Birmingham, Alabama
- Trial of Curcumin to Prevent Progression of Low-risk Prostate Cancer Under Active SurveillancePHASE3 · Recruiting · University of Texas Southwestern Medical Center · Dallas, Texas